Provenienza dei contatti di primo grado di Jack Milwid
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.
11
| Private Company | Investment Managers | 11 |
Related Sciences LLC
Related Sciences LLC Investment ManagersFinance Related Sciences LLC is a data-driven biotech venture creation firm that builds a new class of risk-optimized biotech companies and a unique suite of platform capabilities to design and efficiently manage them. The private company is based in Denver, CO. The company draws upon years of research into the best life science investment and drug discovery models to identify new biological breakthroughs, increase its capital efficiency, reduce risk, and maximize its chances of discovering valuable new medicines for patients with the greatest unmet needs. The company was founded by Adam Kolom, Jeffrey Hammerbacher. Adam Kolom has been the CEO since incorporation.
2
| Holding Company | Investment Managers | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jack Milwid tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
MORGAN STANLEY | Investment Banks/Brokers | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
TPG Capital LLC
TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Analyst | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Corporate Officer/Principal | |
McGill University | College/University | Undergraduate Degree | |
Colgate University | College/University | Undergraduate Degree | |
Gettysburg College | College/University | Undergraduate Degree | |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Clarion Healthcare Consulting | Corporate Officer/Principal | ||
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor | |
Rock Health, Inc.
Rock Health, Inc. Investment ManagersFinance Rock Health Inc (Rock Health) is a venture capital firm founded in 2010 by Halle Taco, Nate Gross and Bill Evans. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin | |
Richard Ivey School of Business | College/University | Undergraduate Degree | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vida Ventures LLC
Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder | |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder | |
J.P. Morgan & Co., Inc. (Delaware)
J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Part of JPMorgan Chase & Co., J.P. Morgan & Co., Inc. is a financial services company based in New York. The American company provides financial services. | Financial Conglomerates | Corporate Officer/Principal | |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | President | |
Phoenix Tissue Repair, Inc.
Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The company is based in Boston, MA. | Pharmaceuticals: Major | President | |
GenomeDx, Inc. (California)
GenomeDx, Inc. (California) Miscellaneous Commercial ServicesCommercial Services GenomeDx, Inc. operates as a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. It offers Decipher and Guidance test. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
VIGIL NEUROSCIENCE, INC. | Biotechnology | Director/Board Member | |
NUVATION BIO INC. | Biotechnology | Director/Board Member | |
OMEGA ALPHA SPAC | Financial Conglomerates | Founder | |
Soufflé Therapeutics, Inc.
Soufflé Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Soufflé Therapeutics, Inc. engages in pharmaceutical research and development services. The company is based in Newton, MA. The CEO of the company is Amir H. Nashat. | Pharmaceuticals: Other | Director/Board Member | |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Rare-X
Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Chairman | |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Investment Managers | Private Equity Investor | |
Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Director/Board Member | |
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011. | Biotechnology | Director/Board Member | |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
BridgeBio Chemistry, Inc. | President |
Statistiche
Distribuzione geografica
Stati Uniti | 42 |
Regno Unito | 3 |
Canada | 3 |
Svizzera | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 19 |
Finance | 15 |
Consumer Services | 9 |
Commercial Services | 6 |
Technology Services | 2 |
Posizioni
Director/Board Member | 48 |
Corporate Officer/Principal | 32 |
Undergraduate Degree | 12 |
Chairman | 12 |
Private Equity Investor | 12 |
Contatti più connessi
Insiders | |
---|---|
James Geraghty | 25 |
Jeremy S. Caldwell | 22 |
Neil Kumar | 18 |
Stefan Vitorovic | 15 |
Michelle Doig | 12 |
Jeffrey Hammerbacher | 9 |
Deborah Palestrant | 8 |
Christina Isacson | 8 |
Adam Kolom | 7 |
Todd Holmes | 7 |
Walter Kowtoniuk | 6 |
John J. Keilty | 5 |
Eric Green | 4 |
- Borsa valori
- Insiders
- Jack Milwid
- Connessioni Società